1,3,5,7-TETRAAZAADAMANTANE BENZOYLGLYCINATE, 95%, 250mg

3-Imidazo[1,2-a]pyridin-2-yl-phenylamine, 95.0%, 1g

Bis(triphenylphosphine)dichloronickel, 98%, 10g

(5-Cyano-4-methylthiophen-2-yl)boronic acid, 95.0%, 250mg

4-METHOXY-7-METHYLBENZO[D]THIAZOL-2-AMINE, 95.0%, 500mg

2-(4-Bromo-2-fluoro-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

(2-Amino-5-(trifluoromethyl)phenyl)(phenyl)methanone, 97.0%, 100mg

4,5,6,7-tetrahydro-1H-indazol-5-amine dihydrochloride, 95.0%, 1g

Colonne di protezione HPLC (analitiche) NUCLEODUR® 100-3 C18 ec 4x3 mm, 4 x 3 mm, 3 Pezzo(i)

(R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-one, 98%, 10g

Carboplatin>98.0%(HPLC)1g

1-(2-Cyanoethyl)-5-nitro-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 95.0%, 5g

Cetilistat>98.0%(HPLC)5g